Abstract:In addition to the well-known use of microbubbles (MBs) as powerful contrast agents for general tissue delineation and perfusion in ultrasound (US) imaging, US-targeted MB destruction (UTMD) has been demonstrated to be an emerging technique for noninvasive drug delivery to tumor sites. However, the very limited drug-loading capacity of conventional MBs remains a great obstacle to their application as an efficacious cancer therapy. In this study, an amphiphilic Janus camptothecin-floxuridine (CF) conjugate was synthesized to engineer CF MBs with ultrahigh drug-loading contents (up to 56.7 ± 2.3%). CF MBs were proven to be an excellent contrast agent to enhance US imaging for identifying the location and size of tumors. Upon local US exposure to burst CF MBs under the guidance of contrast-enhanced US imaging, successful conversion of CF MBs into CF NPs in situ resulted in ~14 times higher drug accumulation of the CF conjugate via the sonoporation effect than that of CF NPs and CF MBs without US. After CF was internalized by tumor cells and its ester bond was hydrolyzed, camptothecin (CPT) and floxuridine (FUDR) were released at an exact 1:1 ratio to achieve coordinated pharmacokinetics, leading to significantly higher tumor growth inhibition in murine tumor models of CF MBs combined with US (~72.4%) than CF NPs (~54.1%) and liposomes loaded with CPT and FUDR (~21.6%). Overall, these results demonstrate that the combination of CF MBs with US is a powerful strategy for remarkably enhancing the combined chemotherapeutic efficacy and greatly reducing the undesirable side effects. Tiny gas-filled bubbles that help microscopes spot tumors can also deliver drug nanoparticles to tumor cells. Microbubbles have resonant properties that enhance the quality of ultrasonic images, and are safe to introduce into the bloodstream. Zhifei Dai from Peking University in Beijing, China, and co-workers have now developed a synthetic procedure that combines two promising anticancer drugs in a complex that spontaneously forms microbubbles following mechanical agitation with a fluorinated gas. Ultrasound imaging demonstrated that these microbubbles could be tracked as they circulated to tumor sites in mice. Then, using minute-long ultrasound applications, the team burst the bubbles and created drug nanoparticles. Therapeutic studies revealed that the ultrasound waves facilitated drug movement across tumor cell membranes, leading to lower rates of tumor growth compared to intravenous injections of the nanoparticles. Amphiphilic Janus camptothecin-floxuridine (CF) conjugate was synthesized for engineering CF microbubbles (CF MBs) with ultrahigh drug-loading contents. CF MBs exhibited excellent capability to enhance ultrasound (US) imaging for identifying the location and size of the tumors, while it can be efficiently converted into CF NPs upon sonication, conducing to remarkably high drug tumor accumulation via sonoporation effect. Both camptothecin (CPT) and floxuridine (FUDR) could be released at an exact 1:1 ratio in the tumor microenvironment, achieving significantly improved therapeutic efficacy. Overall, the CF MBs combining with US technique will provide a step toward the application of targeted theranostics.

Ultrasound Mediated Destruction of Multifunctional Microbubbles for Image Guided Delivery of Oxygen and Drugs

Preparation and Antitumor Activity of Bfgf-Mediated Active Targeting Doxorubicin Microbubbles

Ultrasound-mediated destruction of oxygen and paclitaxel loaded lipid microbubbles for combination therapy in hypoxic ovarian cancer cells

Ultrasound-Responsive Microfluidic Microbubbles For Combination Tumor Treatment

Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Mild Hyperthermia-Induced Bubble-Enhanced Oxygen-Sensitized Radiotherapy.

Ultrasound Contrast Agent Microbubbles with Ultrahigh Loading Capacity of Camptothecin and Floxuridine for Enhancing Tumor Accumulation and Combined Chemotherapeutic Efficacy

Enhancing Photodynamic Therapy Efficacy Against Cancer Metastasis by Ultrasound-Mediated Oxygen Microbubble Destruction to Boost Tumor-Targeted Delivery of Oxygen and Renal-Clearable Photosensitizer Micelles.

The Design of Multifunctional Microbubbles for Ultrasound Image-Guided Cancer Therapy

Microfluidic-Assisted Formation of Multifunctional Monodisperse Microbubbles for Diagnostics and Therapeutics

Multifunctional Nanoparticles for Combining Ultrasonic Tumor Imaging and Targeted Chemotherapy

Ultrasound Triggered Drug Release from 10-Hydroxycamptothecin-loaded Phospholipid Microbubbles for Targeted Tumor Therapy in Mice.

Dual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment

Oxygen and Indocyanine Green Loaded Microparticles for Dual-Mode Imaging and Sonodynamic Treatment of Cancer Cells

Progress and preclinical application status of ultrasound microbubbles

Fabricating Multifunctional Microbubbles and Nanobubbles for Concurrent Ultrasound and Photoacoustic Imaging

Drug-loaded nano-microcapsules delivery system mediated by ultrasound-targeted microbubble destruction: A promising therapy method.

Cytotoxicity Enhancement of DOX-liposome-containing Microbubbles Combined with Ultrasound to the Multi-Drug Resistant Cell

Combination of Focused Ultra Sound and MnO 2 /GOD Loaded Microbubble Nanoparticles in Targeted Tumor Therapy of Breast Cancer

Phase-changeable and bubble-releasing implants for highly efficient HIFU-responsive tumor surgery and chemotherapy

Size-Modulable Nanoprobe for High-Performance Ultrasound Imaging and Drug Delivery against Cancer

Ultrasound-mediated targeted microbubbles: a new vehicle for cancer therapy